The price of CGTX is predicted to go up 3.33%, based on the high correlation periods with BNS. The similarity of these two price pattern on the periods is 92.39%.
CGTX
BNS
Up: 3.33%Similarity: 92.39%
CGTX Revenue Forecast
CGTX EPS Forecast
CGTX FAQs
What is bull’s view on CGTX?
CGTX stock is currently trading at $1.5650, reflecting a sharp decline of 34% following disappointing Phase 2 results for its Alzheimer’s drug. However, analysts maintain a bullish outlook, with HC Wainwright & Co. recently raising the price target to $6, citing long-term potential in its pipeline. The stock's low valuation and sufficient cash runway into mid-2025 make it an attractive speculative buy for high-risk investors.
What is bear's view on CGTX?
CGTX stock is currently bearish, trading at $1.5650 after a sharp 34% drop due to disappointing Phase 2 results for its Alzheimer’s drug. The failure to meet expectations in clinical trials has significantly undermined investor confidence. With limited near-term catalysts and a weak technical setup, further downside risk remains.